Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 03, 2014 01:00 ET | Source: Given Imaging Ltd.

Multimedia Release -- Given Imaging Receives FDA Clearance for PillCam(R) COLON in Patients Following Incomplete Colonoscopy

PillCam COLON is the Only Non-Invasive and Radiation-Free Solution for the Approximately 750,000 Patients in the U.S. Who Experience an Incomplete Colonoscopy Each Year The Company's PillCam COLON...
January 23, 2014 10:37 ET | Source: Given Imaging Ltd.

Given Imaging Announces Results of Special Shareholders' Meeting

YOQNEAM, Israel, Jan. 23, 2014 (GLOBE NEWSWIRE) -- Given Imaging Ltd. (Nasdaq:GIVN) announced that at a special shareholders' meeting held today in Yoqneam, Israel, the shareholders of the Company...
January 02, 2014 07:00 ET | Source: Given Imaging Ltd.

Given Imaging Announces Results of Special Shareholders' Meeting

YOQNEAM, Israel, Jan. 2, 2014 (GLOBE NEWSWIRE) -- Given Imaging Ltd. (Nasdaq:GIVN) today announced the results of a special shareholders' meeting which was held in Yoqneam, Israel on December 31,...
November 11, 2013 01:00 ET | Source: Given Imaging Ltd.

Photo Release -- Given Imaging Receives Reimbursement Approval for PillCam COLON(R) in Japan Effective January 1, 2014

YOQNEAM, Israel, Nov. 11, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that Japan's Central Social...
November 05, 2013 16:47 ET | Source: Given Imaging Ltd.

Given Imaging Reports Third Quarter 2013 Financial Results

Third Quarter 2013 Revenues Increase by 10% to a Record $50 Million PillCam SB Capsules Sales Climb to a Record 63,500 in the Quarter Third Quarter 2013 GAAP EPS Increases 5% to $0.20, Non-GAAP...
October 22, 2013 07:00 ET | Source: Given Imaging Ltd.

Given Imaging to Host Third Quarter 2013 Financial Results Conference Call on November 6, 2013

YOQNEAM, Israel, Oct. 22, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN) today announced that the company will host a conference call on Wednesday, November 6, 2013 at 9:00am ET, 4:00pm Israel...
October 21, 2013 12:30 ET | Source: Given Imaging Ltd.

Given Imaging Announces the Results of Two Recent Studies Underscoring the Economic Value and Clinical Utility of PillCam(R) ESO in Managing Upper GI Bleeding in the Emergency Department Setting

- Cost analysis shows PillCam ESO saves more than $10,000 versus a scoring-based risk stratification strategy for patients at low risk - - PillCam ESO is significantly more effective than...
October 16, 2013 07:01 ET | Source: Given Imaging Ltd.

Studies Presented at ACG Confirm the Use of Given Imaging's High Resolution Manometry and Reflux Products to Measure Esophageal Dysfunction and Symptom Severity Leading to Altered Disease Management

SAN DIEGO, Oct. 16, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced results from multiple studies that...
October 16, 2013 01:01 ET | Source: Given Imaging Ltd.

New Data Confirm Given Imaging's Reflux and Manometry Monitoring Products Improve Detection & Management of GERD and Other Esophageal Disorders

BERLIN, Oct. 16, 2013 (GLOBE NEWSWIRE) -- Given Imaging (Nasdaq:GIVN), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced numerous studies confirming the value...
October 15, 2013 07:01 ET | Source: Given Imaging Ltd.

Given Imaging Announces New Data That Suggests Increased Role for PillCam(R) SB in Guiding Therapy for Patients With Gastrointestinal Bleeding

– Investigators use PillCam SB to determine link between Proton Pump Inhibitor therapy use and Iron Deficiency Anemia – – Additional study reports PillCam SB better than EGD or...